INTELLIGENT BIO SOLUTIONS INC.
Financial highlights
| Metric | FY June 30, 2025 | FY June 30, 2024 | FY June 30, 2023 | FY June 30, 2022 | FY June 30, 2021 |
|---|---|---|---|---|---|
| Revenue | $3.1M | $3.1M | $1.3M | $437,146 | $2.0M |
| Gross profit | $1.2M | $1.4M | $326,668 | — | — |
| Operating income | -$10.6M | -$10.3M | -$12.6M | -$8.3M | -$5.6M |
| Operating expenses | $12.7M | $12.1M | $13.7M | $8.8M | $7.6M |
| Cost of revenue | $1.8M | $1.7M | $930,204 | — | — |
| Cash from operations | -$9.7M | -$9.6M | -$7.4M | -$3.4M | -$11.3M |
| Capital expenditure | $231,838 | $221,426 | — | — | — |
| Free cash flow | -$9.9M | -$9.8M | — | — | — |
| Impairments | — | — | $4.2M | — | — |
| Total assets | $8.2M | $13.8M | $10.4M | $12.4M | $21.9M |
| Total liabilities | $5.4M | $5.6M | $6.7M | $5.8M | $6.9M |
Shares outstanding 2.4M · Free float 40.0%
Annual filing data through FY ended June 30, 2025; float as of June 27, 2026.